Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.660
-0.070 (-4.05%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Seer, Inc. Employees
Seer, Inc. had 124 employees as of December 31, 2025. The number of employees decreased by 10 or -7.46% compared to the previous year.
Employees
124
Change (1Y)
-10
Growth (1Y)
-7.46%
Revenue / Employee
$122,306
Profits / Employee
-$568,460
Market Cap
91.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Inovio Pharmaceuticals | 112 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
| NeurAxis | 24 |
| LeonaBio | 19 |
SEER News
- 4 days ago - The Radoff-JEC Group urges Seer stockholders vote for boardroom change - TheFly
- 4 days ago - The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today - Business Wire
- 7 days ago - Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening - GlobeNewsWire
- 13 days ago - Radoff-JEC issue statement on CEO Farokhzad’s history of ‘value destruction’ - TheFly
- 13 days ago - The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction - Business Wire
- 13 days ago - Seer, Inc. Proxy statement: Proxy filing - Filings
- 13 days ago - Seer, Inc. Proxy statement: Proxy filing - Filings
- 14 days ago - Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign - GlobeNewsWire